ARCHIVES

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Grants Funding: New Funds Moved Into R01s, other Extramural Priorities

December 12, 1997

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

Study Finds Trial Results Reliable At Three Years

July 29, 2005

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006

Rauscher For Cancer Program

May 20, 1977

American Legacy Foundation Says Group is Fighting For Its Survival.

January 7, 2005